Last Updated : December 2, 2009
Details
FilesGeneric Name:
Loteprednol etabonate
Project Status:
Complete
Therapeutic Area:
Post-operative inflammation following cataract surgery
Manufacturer:
Bausch & Lomb
Brand Name:
Lotemax
Project Line:
Reimbursement Review
Project Number:
SR0186-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Post-operative inflammation following cataract surgery
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : December 2, 2009